Nasal dexmedetomidine for acute anxiety in adults
About this title
Read the official source — NCT07550881This study evaluates the safety and effectiveness of Dexmedetomidine for people with anxiety.
Understand this study
What is this study about?
This study evaluates the safety and effectiveness of Dexmedetomidine for people with anxiety.
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- ShanghaiSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 150
- Sponsor
- Tongji University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- China
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07550881
- Official title
Show the full official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating the Efficacy and Safety of Dexmedetomidine Hydrochloride Nasal Spray for the Treatment of Acute Anxiety States in Adults
Recruitment & locations
Shanghai
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the safety and effectiveness of Dexmedetomidine for people with anxiety.
Who is behind this study?
The study sponsor is Tongji University, a university.
Does this study involve medication?
Yes. The study involves medication, including Dexmedetomidine.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
